The post Strategy Makes Largest Bitcoin Purchase Since January appeared on BitcoinEthereumNews.com. Bitmine also continued adding to its crypto holdings with a The post Strategy Makes Largest Bitcoin Purchase Since January appeared on BitcoinEthereumNews.com. Bitmine also continued adding to its crypto holdings with a

Strategy Makes Largest Bitcoin Purchase Since January

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Bitmine also continued adding to its crypto holdings with a fresh ETH purchase in the past week.

Strategy, formerly Microstragegy, announced today, March 2, that it has acquired an additional 3,015 Bitcoin (BTC), according to an X post from the firm. The purchase totalled approximately $204.1 million, at an average price of $67,700 per Bitcoin.

This latest BTC buy marks Strategy’s largest since January and brings its total Bitcoin holdings to 720,737 BTC, further solidifying its status as the largest corporate Bitcoin holder globally, according to data from BitcoinTreasuries. The firm, which pioneered the digital asset treasury (DAT) strategy as far back as 2020, has continued to make weekly BTC purchases in recent months.

Last week’s purchase is its largest since Jan. 20, when Strategy bought 22,305 BTC for an average cost of $91,519, according to its website, which marked its largest single purchase since late 2024.

Bitmine Also Buys ETH

Meanwhile, Bitmine Immersion Technologies continues to hold onto its position as the largest Ethereum DAT company, also announcing a fresh purchase today, according to a press release from the firm. The company accumulated nearly 51,000 ETH in the past week alone, bringing its holdings to 4,473,587 ETH, per the release. Bitmine also noted that it is staking a total of 3,040,483 ETH as of March 1.

The continued accumulation from the two largest DATs comes as BTC and ETH both post 24-hour gains in a broad crypto market rally today, despite the escalating military action in the Middle East, after the United States and Israel launched strikes against Iran this weekend, killing Iranian Supreme Leader Ayatollah Ali Khamenei.

BTC rallied back over $69,000 and ETH pushed over $2,000 today, supported by renewed inflows into spot crypto ETFs at the end of last week.

The DAT trend exploded last year, as an increasing number of publicly traded firms began accumulating not only BTC and ETH, but smaller cap assets. Experts, however, expressed concerns about the risks and questioned the viability of the DAT structure as a long-term strategy, especially for smaller, more volatile crypto assets.

This article was generated with the assistance of AI workflows.

Source: https://thedefiant.io/news/tradfi-and-fintech/strategy-announces-latest-bitcoin-purchase-adds-3015-btc

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$68,029.99
$68,029.99$68,029.99
-0.69%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09